NCT07503379 Evaluation of the Efficacy and Safety of Darolutamide + ADT Combined With Low-dose Docetaxel in mHSPC Status NOT_YET_RECRUITING Phase PHASE2
NCT07389174 Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07112612 Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer Status NOT_YET_RECRUITING Phase N/A